Multivalent glycoconjugates as anti-pathogenic agents A Bernardi, J Jiménez-Barbero, A Casnati, C De Castro, T Darbre, ... Chemical Society Reviews 42 (11), 4709-4727, 2013 | 576 | 2013 |
TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis NN Kuzmich, KV Sivak, VN Chubarev, YB Porozov, ... Vaccines 5 (4), 34, 2017 | 553 | 2017 |
Electrospinning for drug delivery applications: A review A Luraghi, F Peri, L Moroni Journal of Controlled release 334, 463-484, 2021 | 471 | 2021 |
Chemistry of lipid A: at the heart of innate immunity A Molinaro, O Holst, F Di Lorenzo, M Callaghan, A Nurisso, G D'Errico, ... Chemistry–A European Journal 21 (2), 500-519, 2015 | 262 | 2015 |
Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice I Bettoni, F Comelli, C Rossini, F Granucci, G Giagnoni, F Peri, B Costa Glia 56 (12), 1312-1319, 2008 | 255 | 2008 |
Chemo-and stereoselective glycosylation of hydroxylamino derivatives: a versatile approach to glycoconjugates F Peri, P Dumy, M Mutter Tetrahedron 54 (40), 12269-12278, 1998 | 221 | 1998 |
Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists F Peri, M Piazza Biotechnology advances 30 (1), 251-260, 2012 | 206 | 2012 |
Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update: miniperspective F Peri, V Calabrese Journal of medicinal chemistry 57 (9), 3612-3622, 2014 | 188 | 2014 |
The role of carbohydrates in the lipopolysaccharide (LPS)/toll-like receptor 4 (TLR4) signalling F Cochet, F Peri International journal of molecular sciences 18 (11), 2318, 2017 | 178 | 2017 |
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor H Stabile, S Mitola, E Moroni, M Belleri, S Nicoli, D Coltrini, F Peri, A Pessi, ... Blood 109 (5), 1834-1840, 2007 | 172 | 2007 |
Exploring the LPS/TLR4 signal pathway with small molecules F Peri, M Piazza, V Calabrese, G Damore, R Cighetti Biochemical Society Transactions 38 (5), 1390-1395, 2010 | 140 | 2010 |
Metabolism of phosphatidylinositol 4-kinase IIIα-dependent PI4P Is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity A Bianco, V Reghellin, L Donnici, S Fenu, R Alvarez, C Baruffa, F Peri, ... PLoS pathogens 8 (3), e1002576, 2012 | 135 | 2012 |
TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection L Perrin-Cocon, A Aublin-Gex, SE Sestito, KA Shirey, MC Patel, P André, ... Scientific reports 7 (1), 40791, 2017 | 127 | 2017 |
Clustered carbohydrates in synthetic vaccines F Peri Chemical Society Reviews 42 (11), 4543-4556, 2013 | 93 | 2013 |
Novel Tn antigen-containing neoglycopeptides: synthesis and evaluation as anti tumor vaccines L Cipolla, M Rescigno, A Leone, F Peri, B La Ferla, F Nicotra Bioorganic & medicinal chemistry 10 (5), 1639-1646, 2002 | 87 | 2002 |
Glycolipids and benzylammonium lipids as novel antisepsis agents: synthesis and biological characterization M Piazza, C Rossini, S Della Fiorentina, C Pozzi, F Comelli, I Bettoni, ... Journal of medicinal chemistry 52 (4), 1209-1213, 2009 | 82 | 2009 |
Synthesis and Conformational Analysis of Novel N(OCH3)‐linked Disaccharide Analogues F Peri, J Jiménez–Barbero, V García–Aparicio, I Tvaroška, F Nicotra Chemistry–A European Journal 10 (6), 1433-1444, 2004 | 79 | 2004 |
Toll-like receptor 4–induced glycolytic burst in human monocyte-derived dendritic cells results from p38-dependent stabilization of HIF-1α and increased hexokinase II expression L Perrin-Cocon, A Aublin-Gex, O Diaz, C Ramière, F Peri, P André, ... The Journal of Immunology 201 (5), 1510-1521, 2018 | 75 | 2018 |
Evidence of a specific interaction between new synthetic antisepsis agents and CD14 M Piazza, L Yu, A Teghanemt, T Gioannini, J Weiss, F Peri Biochemistry 48 (51), 12337-12344, 2009 | 71 | 2009 |
Glycoconjugates in cancer therapy L Cipolla, F Peri, C Airoldi Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2008 | 70 | 2008 |